Fortress Investment Group LLC
Position in APLS — Apellis Pharmaceuticals, Inc.
CIK 1380393
NEW YORK, NY
Position in APLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,609,200
New position
Shares Held
40,000
first reported quarter
Ownership
0.031%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Fortress Investment Group LLC holds $9,923,267 across 6 Biotechnology names. APLS ranks #3 (16.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FOLD |
AMICUS THERAPEUTICS, INC.
|
245,900 | $3,555,714 | |
| 2 | ACLX |
Arcellx, Inc.
|
18,183 | $2,087,772 | |
| 3 | APLS |
Apellis Pharmaceuticals, Inc.
This page
|
40,000 | $1,609,200 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
30,000 | $1,581,600 | |
| 5 | CNTA |
Centessa Pharmaceuticals plc
|
20,000 | $794,400 | |
| 6 | RNA |
Atrium Therapeutics, Inc.
|
22,033 | $294,581 |
All Filings in APLS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,609,200 | 40,000 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||